9th Circ. Nixes Pharmacies' Pfizer-Wyeth Merger Suit
The Ninth Circuit on Thursday upheld the dismissal of a group of pharmacies' antitrust challenge to Pfizer Inc.'s $68 billion merger with Wyeth, saying the pharmacies failed to specify a relevant...To view the full article, register now.
Already a subscriber? Click here to view full article